Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Thor Straten

Showing results (141-150 of 171) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2013
Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenaseTrine Zeeberg Iversen, Lotte Engell-Noerregaard, Eva Ellebaek, et al.
Blood|November 23, 2006
RhoH is important for positive thymocyte selection and T-cell receptor signalingTatjana Dorn, Ursula Kuhn, Gerd Bungartz, et al.
Vaccines|May 7, 2025
Vaccination Against RhoC in Prostate Cancer Patients Induces Potent and Long-Lasting CD4<sup>+</sup> T Cell Responses with Cytolytic Potential in the Absence of Clinical Efficacy: A Randomized Phase II TrialSara Fresnillo Saló, Juliane Schuhmacher, Anne Rahbech, et al.
Cancer Immunology, Immunotherapy : CII|May 9, 2012
Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanomaJürgen C Becker, Mads H Andersen, Valeska Hofmeister-Müller, et al.
The Journal of Allergy and Clinical Immunology|August 21, 2018
Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivityCaroline B K Mathiesen, Michael C Carlsson, Stephanie Brand, et al.
Cell Metabolism|February 21, 2016
Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and RedistributionLine Pedersen, Manja Idorn, Gitte H Olofsson, et al.
Frontiers in Immunology|May 23, 2022
Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell SuppressionAna Micaela Carnaz Simões, Morten Orebo Holmström, Pia Aehnlich, et al.
BMC Cancer|March 6, 2022
High Intensity Aerobic exercise training and Immune cell Mobilization in patients with lung cancer (HI AIM)-a randomized controlled trialGitte Holmen Olofsson, Marta Kramer Mikkelsen, Anne-Mette Ragle, et al.
Nature Biomedical Engineering|June 29, 2026
The evolving role of cytokines for CAR-T cell manufacturing and beyondMar Guaza-Lasheras, Johanna Nimmerfroh, Dominic Schwarz, et al.
Journal for Immunotherapy of Cancer|March 15, 2019
Collagen density regulates the activity of tumor-infiltrating T cellsDorota E Kuczek, Anne Mette H Larsen, Marie-Louise Thorseth, et al.
Pageof 18

Showing results (141-150 of 171) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2013
Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenaseTrine Zeeberg Iversen, Lotte Engell-Noerregaard, Eva Ellebaek, et al.
Blood|November 23, 2006
RhoH is important for positive thymocyte selection and T-cell receptor signalingTatjana Dorn, Ursula Kuhn, Gerd Bungartz, et al.
Vaccines|May 7, 2025
Vaccination Against RhoC in Prostate Cancer Patients Induces Potent and Long-Lasting CD4<sup>+</sup> T Cell Responses with Cytolytic Potential in the Absence of Clinical Efficacy: A Randomized Phase II TrialSara Fresnillo Saló, Juliane Schuhmacher, Anne Rahbech, et al.
Cancer Immunology, Immunotherapy : CII|May 9, 2012
Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanomaJürgen C Becker, Mads H Andersen, Valeska Hofmeister-Müller, et al.
The Journal of Allergy and Clinical Immunology|August 21, 2018
Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivityCaroline B K Mathiesen, Michael C Carlsson, Stephanie Brand, et al.
Cell Metabolism|February 21, 2016
Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and RedistributionLine Pedersen, Manja Idorn, Gitte H Olofsson, et al.
Frontiers in Immunology|May 23, 2022
Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell SuppressionAna Micaela Carnaz Simões, Morten Orebo Holmström, Pia Aehnlich, et al.
BMC Cancer|March 6, 2022
High Intensity Aerobic exercise training and Immune cell Mobilization in patients with lung cancer (HI AIM)-a randomized controlled trialGitte Holmen Olofsson, Marta Kramer Mikkelsen, Anne-Mette Ragle, et al.
Nature Biomedical Engineering|June 29, 2026
The evolving role of cytokines for CAR-T cell manufacturing and beyondMar Guaza-Lasheras, Johanna Nimmerfroh, Dominic Schwarz, et al.
Journal for Immunotherapy of Cancer|March 15, 2019
Collagen density regulates the activity of tumor-infiltrating T cellsDorota E Kuczek, Anne Mette H Larsen, Marie-Louise Thorseth, et al.
Pageof 18